Real‐world predictors of progression to type 2 diabetes among adults with prediabetes
What is the context and purpose of this research study? This research study looked at why some adults with prediabetes were more likely than others to develop type 2 diabetes (T2D). The researchers wanted to know if factors like age, sex, race, history of health conditions (such as obesity, heart disease, and sleep disorders), and abnormal lab tests (like elevated blood sugar levels) could predict who will get T2D. What was done? The researchers conducted a study using a US database of insurance and medical records from 2016 to 2024. The researchers compared two groups: 39 281 adults with prediabetes who developed T2D and 58 751 adults with prediabetes who did not develop T2D. The researchers looked for patterns in these groups and used statistics to identify risk factors. What were the main results? The study found that middle-aged adults (35-64 years old) and those with health problems like obesity, heart disease, sleep apnea, neuropathy, and liver disease were more likely to get T2D. These patterns were similar across patients of different races and genders. However, Black and Hispanic patients had a higher risk of T2D compared to White patients. There was no difference in the risk of developing T2D between patients with Asian or Other ethnicities and White patients. What is the originality and relevance of this study? This study is important because it identifies factors that increase the risk of developing T2D in people with prediabetes. It suggests that age, certain health conditions, and race can affect this risk. These findings can help doctors create better treatment and prevention plans for high-risk patients.
Authors
- Riddhi Doshi (ORCID: https://orcid.org/0000-0002-1439-1511)
- Carolina Solis‐Herrera (ORCID: https://orcid.org/0000-0002-6215-9418)
- Michael Radin
- Tyler J. Dunn (ORCID: https://orcid.org/0000-0002-8312-7335)
- Justin Chen (ORCID: https://orcid.org/0009-0002-7960-9697)
- Victoria Divino
- Dajun Tian
- Lin Xie
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- Novo Nordisk (United States) (US)
- IQVIA (United States) (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1111/dom.70583
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00